Kamel Laribi
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 31
- Acute Myeloid Leukemia Research 15
- Multiple Myeloma Research and Treatments 12
- Genetics 27
- Chronic Lymphocytic Leukemia Research 16
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
- Co-authors
- Alix Baugier de Materre (13 shared papers)Li Zhu (2 shared papers)Kazuyuki Shimizu (2 shared papers)Noopur Raje (2 shared papers)Brian G.M. Durie (2 shared papers)Wojciech Legieć (2 shared papers)G. David Roodman (2 shared papers)Evangelos Terpos (2 shared papers)
- Journals
- Blood (16 papers)British Journal of Haematology (5 papers)Annals of Hematology (5 papers)Journal of Clinical Oncology (4 papers)European Journal Of Haematology (3 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Kamel Laribi
56 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Hematology 604
- Genetics 321
- Oncology 606
- Pathology and Forensic Medicine 329
- Dermatology 140
Countries citing papers authored by Kamel Laribi
This map shows the geographic impact of Kamel Laribi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamel Laribi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamel Laribi more than expected).
Fields of papers citing papers by Kamel Laribi
This network shows the impact of papers produced by Kamel Laribi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamel Laribi. The network helps show where Kamel Laribi may publish in the future.
Co-authors
The 25 scholars most cited alongside Kamel Laribi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study Hit paper breakdown → | 2018 | 307 |
| 2 | 2016 | 186 | |
| 3 | 2001 | 67 | |
| 4 | 2013 | 57 | |
| 5 | 2018 | 50 | |
| 6 | 2014 | 46 | |
| 7 | 2018 | 45 | |
| 8 | 2020 | 41 | |
| 9 | 2016 | 37 | |
| 10 | 2018 | 35 | |
| 11 | 2016 | 31 | |
| 12 | 2015 | 30 | |
| 13 | 2017 | 21 | |
| 14 | 2018 | 19 | |
| 15 | 2012 | 17 | |
| 16 | 2021 | 16 | |
| 17 | 2021 | 16 | |
| 18 | 2015 | 16 | |
| 19 | 2015 | 15 | |
| 20 | 2018 | 14 |
About Kamel Laribi
Kamel Laribi is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Molecular Biology, having authored 62 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (16 papers), Acute Myeloid Leukemia Research (15 papers), Multiple Myeloma Research and Treatments (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), CNS Lymphoma Diagnosis and Treatment (7 papers), Immunodeficiency and Autoimmune Disorders (6 papers) and Cutaneous lymphoproliferative disorders research (6 papers). The work is most often cited by research in Hematology (604 citations), Genetics (321 citations), Oncology (606 citations), Pathology and Forensic Medicine (329 citations) and Dermatology (140 citations). Kamel Laribi has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Alix Baugier de Materre, Li Zhu, Kazuyuki Shimizu, Noopur Raje, Brian G.M. Durie, Wojciech Legieć, G. David Roodman, Evangelos Terpos, Douglas Warner and Wolfgang Willenbacher. Their work appears in journals such as Blood, British Journal of Haematology, Annals of Hematology, Journal of Clinical Oncology and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.